Protect Pharmaceutical Corporation
PRTT · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $33 | $149 | $8 | $23 |
| - Cash | $18 | $18 | $1 | $40 |
| + Debt | $4 | $4 | $3 | $12 |
| Enterprise Value | $19 | $134 | $9 | -$5 |
| Revenue | $132 | $136 | $82 | $79 |
| % Growth | -2.9% | 66.5% | 3.8% | – |
| Gross Profit | $73 | $73 | $42 | $44 |
| % Margin | 54.9% | 53.8% | 50.8% | 56.3% |
| EBITDA | $58 | $48 | $25 | $28 |
| % Margin | 43.6% | 35% | 31.2% | 35.7% |
| Net Income | $56 | $46 | $22 | $20 |
| % Margin | 42.6% | 33.7% | 27.4% | 25.6% |
| EPS Diluted | 0.98 | 0.8 | 0.43 | 0.36 |
| % Growth | 22.5% | 86% | 19.4% | – |
| Operating Cash Flow | $13 | $4 | -$67 | $11 |
| Capital Expenditures | -$3 | -$4 | -$2 | -$75 |
| Free Cash Flow | $10 | $0 | -$69 | -$65 |